Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zheng-Shu Xu"'
Autor:
Chun-Tuan Li, Jianda Hu, Ting Yang, Xu Lin, Zheng-Shu Xu, Xiong-Peng Zhu, Jian-Liang Zhuang, Zhizhe Chen
Publikováno v:
Chinese medical journal. 121(21)
BACKGROUND Survivin is a rather specific gene in tumor tissue. We transfected dendritic cells (DCs) with recombinant adenovirus (Ad) containing survivin gene and granulocyte-macrophage colony-stimulating factor (GM-CSF) gene and tested the inducing e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e46aa611062bd681f9fb007b024a17c
https://pubmed.ncbi.nlm.nih.gov/19080181
https://pubmed.ncbi.nlm.nih.gov/19080181
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 15(3)
This study was purposed to investigate the immunological effects of modified dendritic cells (DCs) in inducing cytotoxic T cells (CTLs) effect against lymphoma cells. The DCs were derived from human peripheral blood and transfected with recombined ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f2207f9bd47d596cac0131fa0c2a80f8
https://pubmed.ncbi.nlm.nih.gov/17605872
https://pubmed.ncbi.nlm.nih.gov/17605872
Autor:
Xiong-Peng, Zhu, Zhi-Zhe, Chen, Xu, Lin, Jian-Da, Hu, Chun-Tuan, Li, Ting, Yang, Zheng-Shu, Xu, Lu-Lu, Lü, Cai-Ping, Chen, Lang-Hui, Zhang
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 14(4)
The study was aimed to construct the recombinant adenovirus vectors containing human survivin gene, and to investigate their expression in transfected dendritic cells. Full length cDNA encoding survivin was obtained by PCR amplification from plasmid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4d4ff8e9e715fdf112dba7a8fb452060
https://pubmed.ncbi.nlm.nih.gov/16928323
https://pubmed.ncbi.nlm.nih.gov/16928323
Autor:
Ting Yang, Xu Lin, Lulu Lv, Zhizhe Chen, Xiong-Peng Zhu, Zheng-Shu Xu, Jianda Hu, Chun-Tuan Li
Publikováno v:
Blood. 108:5483-5483
Relapse after chemotherapy could lead to poor prognosis in patients with leukemia. By using tumor-specific immunotherapy to eradicate minimal residual diseases could prevent disease relapse. Our study aims at exploring whether peripheral blood derive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f7b4e13352cb92bdf7eef262ca186f2
https://doi.org/10.1182/blood.v108.11.5483.5483
https://doi.org/10.1182/blood.v108.11.5483.5483